Index of reports
> Cases with Thrombocytopenia (107)
Below is the selection of side effect reports (a.k.a. adverse event reports) related to Cytarabine where reactions include thrombocytopenia. The selected reports were submitted to the FDA during the sample period of about a year.
Reports 1 - 30 of 107 Next >>
Possible Cytarabine side effects in male
Reported by a physician from France on 2012-08-07
Patient: male, weighing 80.0 kg (176.0 pounds)
Reactions: Anaemia, Febrile Bone Marrow Aplasia, Erythema, Thrombocytopenia
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Vidaza
Dosage: 1330 milligram
Start date: 2012-04-18
End date: 2012-04-24
Ccnu
Administration route: Oral
Start date: 2012-04-18
End date: 2012-04-18
Idarubicin HCL
Start date: 2012-04-18
End date: 2012-04-22
Revlimid
Dosage: 10 milligram
Administration route: Oral
Start date: 2012-06-18
End date: 2012-06-28
Cytarabine
Start date: 2012-04-18
End date: 2012-04-24
Other drugs received by patient: Bisoprolol Fumarate; Rocephin; Amikacin
Possible Cytarabine side effects in 66 year old male
Reported by a physician from France on 2012-08-07
Patient: 66 year old male, weighing 82.0 kg (180.4 pounds)
Reactions: Stenotrophomonas Infection, Coma, Device Related Infection, Pyrexia, Hypernatraemia, Loss of Consciousness, Malaise, Meningeal Disorder, Oedema Peripheral, Eye Movement Disorder, Blood Creatinine Increased, Cough, Hyperphosphataemia, Pleurisy, Pancytopenia, General Physical Health Deterioration, Aplasia, Convulsion, Nephrogenic Diabetes Insipidus, Neutropenia, Citrobacter Infection, Generalised Oedema, Hyperuricaemia, Myalgia, Weight Increased, Pleural Effusion, Crepitations, Thrombocytopenia, Jugular Vein Thrombosis, Candidiasis, Renal Failure Acute, Dyspnoea, Mucosal Inflammation, Diarrhoea, Monoparesis, Inflammation
Adverse event resulted in: death, life threatening event, hospitalization, disablity
Drug(s) suspected as cause:
Treanda
Dosage: 180 mg/m2 daily; 358.5 mg on day 1 + 2 of each cycle
Indication: Bone Marrow Conditioning Regimen
Start date: 2012-02-27
End date: 2012-02-28
Melphalan Hydrochloride
Dosage: 250 mg total dose
Indication: Bone Marrow Conditioning Regimen
Start date: 2012-03-03
Cytarabine
Indication: Bone Marrow Conditioning Regimen
Start date: 2012-02-28
End date: 2012-03-02
Etoposide
Dosage: 400 mg/m2 daily; uid/qd
Indication: Bone Marrow Conditioning Regimen
Start date: 2012-02-28
End date: 2012-03-02
Treanda
Indication: non-Hodgkin's Lymphoma
Possible Cytarabine side effects in female
Reported by a physician from Netherlands on 2012-08-02
Patient: female, weighing 73.0 kg (160.6 pounds)
Reactions: Bronchopulmonary Aspergillosis, Respiratory Failure, Pancytopenia, Neutropenia, Thrombocytopenia, Cerebral Haemorrhage, Influenza
Adverse event resulted in: death, life threatening event, hospitalization
Drug(s) suspected as cause:
Amsacrine
Dosage: 225 mg, unk
Indication: Acute Myeloid Leukaemia
Start date: 2012-05-10
Clofarabine
Dosage: 19 mg, qd; day 1 to 5; cycles i and ii
Indication: Acute Myeloid Leukaemia
Start date: 2012-05-07
Cytarabine
Dosage: 1900 mg, unk
Indication: Acute Myeloid Leukaemia
Start date: 2012-05-07
Other drugs received by patient: Amphotericin B; Meropenem; Vancomycin; Voriconazole
Possible Cytarabine side effects in
Reported by a physician from France on 2012-08-02
Patient:
Reactions: Haematuria, Febrile Bone Marrow Aplasia, Thrombocytopenia
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Cytarabine
Dosage: 19.7 mg, qd
Indication: Myelodysplastic Syndrome
Start date: 2011-02-09
End date: 2011-02-22
MK-0683
Dosage: 400 mg, qd
Administration route: Oral
Indication: Myelodysplastic Syndrome
Start date: 2011-02-09
End date: 2011-02-22
Other drugs received by patient: Paroxetine HCL; Prednisone TAB; Potassium Chloride; Tenoretic
Possible Cytarabine side effects in
Reported by a physician from France on 2012-08-01
Patient:
Reactions: Hyperthermia, Embolism, Anaemia, General Physical Health Deterioration, Thrombocytopenia
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Vorinostat-Mycosis Fungoides
Dosage: 400 mg, qd
Administration route: Oral
Indication: Myelodysplastic Syndrome
Start date: 2011-02-15
End date: 2011-02-28
Vorinostat-Mycosis Fungoides
Dosage: 400 mg, qd
Administration route: Oral
Start date: 2011-03-21
End date: 2011-04-03
Cytarabine
Dosage: 18.4 mg, qd
Start date: 2011-02-15
End date: 2011-02-28
Cytarabine
Dosage: 36.8 mg, qd
Start date: 2011-03-21
End date: 2011-04-06
Other drugs received by patient: Plavix; Preterax (Indapamide (+) Perindopril Erbumine); Vfend; Omeprazole
Possible Cytarabine side effects in male
Reported by a health professional (non-physician/pharmacist) from France on 2012-07-30
Patient: male
Reactions: Confusional State, Pulmonary Hypertension, Febrile Infection, Pyrexia, Mixed Liver Injury, Multi-Organ Failure, Enterovesical Fistula, Bone Marrow Failure, Pneumothorax, Acute Respiratory Distress Syndrome, Thrombocytopenia, Metabolic Acidosis, Haemoptysis, Intestinal Obstruction, Appendicitis, Lung Disorder, Renal Impairment, Zygomycosis, Respiratory Acidosis, Oliguria, Aspergillosis, Sinus Tachycardia, Septic Shock, Asthenia
Adverse event resulted in: death, hospitalization
Drug(s) suspected as cause:
Afinitor
Dosage: 10 mg
Administration route: Oral
Start date: 2008-03-19
Daunorubicin HCL
Dosage: unk
Indication: Acute Myeloid Leukaemia
Start date: 2008-03-13
End date: 2008-03-15
Afinitor
Dosage: 10 mg
Administration route: Oral
Indication: Acute Myeloid Leukaemia
Start date: 2008-03-13
Cytarabine
Dosage: unk
Indication: Acute Myeloid Leukaemia
Start date: 2008-03-13
End date: 2008-03-19
Other drugs received by patient: Vancomycin
Possible Cytarabine side effects in 46 year old female
Reported by a health professional (non-physician/pharmacist) from United States on 2012-07-27
Patient: 46 year old female
Reactions: Pancreatic Infarction, Unresponsive To Stimuli, Myelodysplastic Syndrome, Pyrexia, Pallor, Cerebral Haemorrhage, Skin Discolouration, Diarrhoea Haemorrhagic, Small Intestinal Haemorrhage, Apnoea, Thrombocytopenia, Cough, Candidiasis, Hepatosplenomegaly, Dyspnoea, Pain in Extremity, Anaemia, Pulmonary Haemorrhage, Zygomycosis, Diarrhoea, Hemisensory Neglect, Lung Infiltration, Asthenia, Hepatic Infarction
Adverse event resulted in: death
Drug(s) suspected as cause:
Doxorubicin Hydrochloride
Indication: Diffuse Large B-Cell Lymphoma
Etoposide
Indication: Diffuse Large B-Cell Lymphoma
Rituximab
Indication: Diffuse Large B-Cell Lymphoma
Idarubicin HCL
Dosage: 12 mg/m2, unk
Indication: Myelodysplastic Syndrome
Carmustine
Indication: Diffuse Large B-Cell Lymphoma
Prednisone
Indication: Diffuse Large B-Cell Lymphoma
Suberoylanilide Hydroxamic Acid
Dosage: 500 mg, tid
Administration route: Oral
Indication: Myelodysplastic Syndrome
Cytarabine
Indication: Diffuse Large B-Cell Lymphoma
Cyclophosphamide
Indication: Diffuse Large B-Cell Lymphoma
Oncovin
Indication: Diffuse Large B-Cell Lymphoma
Other drugs received by patient: Radiotherapy
Possible Cytarabine side effects in male
Reported by a physician from France on 2012-07-27
Patient: male, weighing 80.0 kg (176.0 pounds)
Reactions: Anaemia, Febrile Bone Marrow Aplasia, Thrombocytopenia, Erythema
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Revlimid
Dosage: 10 milligram
Administration route: Oral
Start date: 2012-06-18
End date: 2012-06-28
Vidaza
Dosage: 1330 milligram
Start date: 2012-04-18
End date: 2012-04-24
Cytarabine
Start date: 2012-04-18
End date: 2012-04-24
Ccnu
Administration route: Oral
Start date: 2012-04-18
End date: 2012-04-18
Idarubicin HCL
Start date: 2012-04-18
End date: 2012-04-22
Other drugs received by patient: Bisoprolol Fumarate; Amikacin; Rocephin
Possible Cytarabine side effects in female
Reported by a physician from Netherlands on 2012-07-27
Patient: female, weighing 73.0 kg (160.6 pounds)
Reactions: Bronchopulmonary Aspergillosis, Respiratory Failure, Pancytopenia, Thrombocytopenia, Cerebral Haemorrhage, Influenza
Adverse event resulted in: death, life threatening event, hospitalization
Drug(s) suspected as cause:
Cytarabine
Dosage: 1900 mg, unk
Indication: Acute Myeloid Leukaemia
Start date: 2012-05-07
Clofarabine
Dosage: 19 mg, unk
Indication: Acute Myeloid Leukaemia
Start date: 2012-05-07
Amsacrine
Dosage: 225 mg, unk
Indication: Acute Myeloid Leukaemia
Start date: 2012-05-10
Other drugs received by patient: Meropenem; Vancomycin; Amphotericin B
Possible Cytarabine side effects in female
Reported by a pharmacist from Italy on 2012-07-25
Patient: female
Reactions: Intestinal Ischaemia, NO Therapeutic Response, Thrombocytopenia, Haematotoxicity
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Vidaza
Dosage: dose reduced
Start date: 2012-03-01
Vidaza
Start date: 2012-01-01
Vidaza
Dosage: 100 milligram
Start date: 2012-02-10
End date: 2012-02-15
Cytarabine
Start date: 2012-01-01
End date: 2012-02-01
Other drugs received by patient: Norvasc; Tenoretic
Possible Cytarabine side effects in female
Reported by a physician from Netherlands on 2012-07-23
Patient: female, weighing 73.0 kg (160.6 pounds)
Reactions: Bronchopulmonary Aspergillosis, Respiratory Failure, Pancytopenia, Thrombocytopenia, Cerebral Haemorrhage, Influenza
Adverse event resulted in: death, life threatening event, hospitalization
Drug(s) suspected as cause:
Cytarabine
Dosage: 1900 mg, unk
Indication: Acute Myeloid Leukaemia
Start date: 2012-05-07
Amsacrine
Dosage: 225 mg, unk
Indication: Acute Myeloid Leukaemia
Start date: 2012-05-10
Clofarabine
Dosage: 19 mg, unk
Indication: Acute Myeloid Leukaemia
Start date: 2012-05-07
Other drugs received by patient: Meropenem; Vancomycin; Amphotericin B
Possible Cytarabine side effects in 50 year old female
Reported by a health professional (non-physician/pharmacist) from Canada on 2012-07-17
Patient: 50 year old female
Reactions: Haemoptysis, Refractoriness To Platelet Transfusion, Pancytopenia, Petechiae, Febrile Neutropenia, Pyrexia, Alveolitis Allergic, Panniculitis, Colitis, Thrombocytopenia, Klebsiella Sepsis, Laryngospasm
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Cytarabine
Dosage: 100 mg/m2, on days 1-7
Indication: Acute Myeloid Leukaemia
Idarubicin Hydrochloride
Dosage: 12 mg/m2, on days 1-3
Indication: Acute Myeloid Leukaemia
Mitoxantrone Hydrochloride
Dosage: 10 mg/m2, on days 1-5
Indication: Acute Myeloid Leukaemia
Etoposide
Dosage: 100 mg/m2, on days 1-5
Indication: Acute Myeloid Leukaemia
Possible Cytarabine side effects in female
Reported by a physician from Netherlands on 2012-07-17
Patient: female, weighing 73.0 kg (160.6 pounds)
Reactions: Pneumonia, Respiratory Failure, Pancytopenia, Thrombocytopenia, Cerebral Haemorrhage, Influenza
Adverse event resulted in: death, life threatening event, hospitalization
Drug(s) suspected as cause:
Clofarabine
Dosage: 19 mg, unk
Indication: Acute Myeloid Leukaemia
Start date: 2012-05-07
End date: 2012-05-11
Amsacrine
Dosage: 225 mg, unk
Indication: Acute Myeloid Leukaemia
Start date: 2012-05-10
End date: 2012-05-12
Cytarabine
Dosage: 3800 mg, unk
Indication: Acute Myeloid Leukaemia
Start date: 2012-05-07
End date: 2012-05-12
Other drugs received by patient: Amphotericin B; Meropenem; Vancomycin
Possible Cytarabine side effects in male
Reported by a physician from France on 2012-07-12
Patient: male, weighing 61.5 kg (135.3 pounds)
Reactions: Haemorrhagic Stroke, Thrombocytopenia
Adverse event resulted in: death
Drug(s) suspected as cause:
Cytarabine
Dosage: 3650 mg, qd
Indication: Acute Myeloid Leukaemia
Start date: 2012-05-22
End date: 2012-06-11
Cerubidine
Dosage: 110 mg, qd
Indication: Acute Myeloid Leukaemia
Start date: 2012-05-22
End date: 2012-06-09
Afinitor
Dosage: 70 mg, unk
Administration route: Oral
Indication: Acute Myeloid Leukaemia
Start date: 2012-05-22
End date: 2012-05-28
Other drugs received by patient: Ondansetron; Emend; Glucose
Possible Cytarabine side effects in 50 year old female
Reported by a health professional (non-physician/pharmacist) from Canada on 2012-07-06
Patient: 50 year old female
Reactions: Haemoptysis, Refractoriness To Platelet Transfusion, Petechiae, Pancytopenia, Febrile Neutropenia, Pyrexia, Alveolitis Allergic, Death, Panniculitis, Colitis, Thrombocytopenia, Laryngospasm, Klebsiella Sepsis
Adverse event resulted in: death, hospitalization
Drug(s) suspected as cause:
Immune Globulin NOS
Indication: Pancytopenia
Mitoxantrone
Dosage: 10 mg/m2 on d1-5; 2nd induction chemotherapy
Indication: Acute Myeloid Leukaemia
Idarubicin HCL
Dosage: 12 mg/m2 on d1-3; induction chemotherapy
Indication: Acute Myeloid Leukaemia
Cytarabine
Dosage: 100 mg/m2 on d1-7; induction chemotherapy
Indication: Acute Myeloid Leukaemia
Etoposide
Dosage: 100 mg/m2 on d1-5; 2nd induction chemotherapy
Indication: Acute Myeloid Leukaemia
Other drugs received by patient: Vercyte
Possible Cytarabine side effects in 50 year old female
Reported by a health professional (non-physician/pharmacist) from Canada on 2012-07-06
Patient: 50 year old female
Reactions: Haemoptysis, Refractoriness To Platelet Transfusion, Petechiae, Febrile Neutropenia, Pancytopenia, Pyrexia, Alveolitis Allergic, Panniculitis, Colitis, Thrombocytopenia, Klebsiella Sepsis
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Idarubicin HCL
Dosage: 12 mg/m2 on d1-3; induction chemotherapy
Indication: Acute Myeloid Leukaemia
Cytarabine
Dosage: 100 mg/m2 on d1-7; induction chemotherapy
Indication: Acute Myeloid Leukaemia
Mitoxantrone
Dosage: 10 mg/m2 on d1-5; 2nd induction chemotherapy
Indication: Acute Myeloid Leukaemia
Etoposide
Dosage: 100 mg/m2 on d1-5; 2nd induction chemotherapy
Indication: Acute Myeloid Leukaemia
Other drugs received by patient: Vercyte
Possible Cytarabine side effects in 50 year old female
Reported by a health professional (non-physician/pharmacist) from Canada on 2012-07-06
Patient: 50 year old female
Reactions: Haemoptysis, Refractoriness To Platelet Transfusion, Pancytopenia, Petechiae, Febrile Neutropenia, Pyrexia, Alveolitis Allergic, Panniculitis, Colitis, Thrombocytopenia, Klebsiella Sepsis
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Idarubicin HCL
Dosage: 12 mg/m2 on d1-3; induction chemotherapy
Indication: Acute Myeloid Leukaemia
Mitoxantrone
Dosage: 10 mg/m2 on d1-5; 2nd induction chemotherapy
Indication: Acute Myeloid Leukaemia
Etoposide
Dosage: 100 mg/m2 on d1-5; 2nd induction chemotherapy
Indication: Acute Myeloid Leukaemia
Cytarabine
Dosage: 100 mg/m2 on d1-7; induction chemotherapy
Indication: Acute Myeloid Leukaemia
Other drugs received by patient: Vercyte
Possible Cytarabine side effects in female
Reported by a pharmacist from Italy on 2012-07-06
Patient: female
Reactions: Intestinal Ischaemia, NO Therapeutic Response, Thrombocytopenia, Haematotoxicity
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Vidaza
Dosage: dose reduced
Start date: 2012-03-01
Vidaza
Start date: 2012-01-01
Cytarabine
Start date: 2012-01-01
End date: 2012-02-01
Vidaza
Dosage: 100 milligram
Start date: 2012-02-10
End date: 2012-02-15
Other drugs received by patient: Tenoretic; Norvasc
Possible Cytarabine side effects in
Reported by a health professional (non-physician/pharmacist) from China on 2012-07-02
Patient:
Reactions: Thrombocytosis, NO Therapeutic Response, Febrile Neutropenia, Bone Marrow Failure, Neutropenia, Thrombocytopenia
Drug(s) suspected as cause:
Cytarabine
Dosage: 10 mg/m2, in 1 cyclical
Indication: Myeloid Leukaemia
Cytarabine
Dosage: 10 mg/m2, in 1 cyclical
Indication: Myelodysplastic Syndrome
Decitabine
Dosage: 15 mg/m2, in 1 cyclical, intravenous
Indication: Myeloid Leukaemia
Aclarubicin (Aclarubicin) Unspecified
Dosage: 10 mg, in 1 cyclical
Indication: Myeloid Leukaemia
Aclarubicin (Aclarubicin) Unspecified
Dosage: 10 mg, in 1 cyclical
Indication: Myelodysplastic Syndrome
Granulocyte Colony Stimulating Factor (Granulocyte Colony Stimulating
Indication: Myelodysplastic Syndrome
Granulocyte Colony Stimulating Factor (Granulocyte Colony Stimulating
Indication: Myeloid Leukaemia
Other drugs received by patient: Hydroxyurea; Homoharringtonine (Homoharringtonine)
Possible Cytarabine side effects in male
Reported by a physician from France on 2012-07-02
Patient: male, weighing 61.5 kg (135.3 pounds)
Reactions: Haemorrhagic Stroke, Thrombocytopenia
Adverse event resulted in: death
Drug(s) suspected as cause:
Cerubidine
Dosage: 110 mg, qd
Indication: Acute Myeloid Leukaemia
Start date: 2012-05-22
End date: 2012-06-09
Cytarabine
Dosage: 3650 mg, qd
Indication: Acute Myeloid Leukaemia
Start date: 2012-05-22
End date: 2012-06-11
Afinitor
Dosage: 70 mg, unk
Administration route: Oral
Start date: 2012-05-22
End date: 2012-05-28
Other drugs received by patient: Ondansetron; Emend; Glucose
Possible Cytarabine side effects in 50 year old female
Reported by a health professional (non-physician/pharmacist) from Canada on 2012-06-29
Patient: 50 year old female
Reactions: Mouth Haemorrhage, Haemoptysis, Acute Myeloid Leukaemia, Petechiae, Febrile Neutropenia, Pancytopenia, Pyrexia, Alveolitis Allergic, Panniculitis, Colitis, Thrombocytopenia, Laryngospasm, Klebsiella Sepsis
Adverse event resulted in: death, life threatening event, hospitalization
Drug(s) suspected as cause:
Mitoxantrone
Dosage: 10 mg/m2, unk
Indication: Acute Myeloid Leukaemia
Cytarabine
Dosage: 100 mg/m2, on days 1 to 7
Indication: Acute Myeloid Leukaemia
Idarubicin HCL
Dosage: 12 mg/m2, on days 1 and 3
Indication: Acute Myeloid Leukaemia
Etoposide
Dosage: 100 mg/m2 on days 1-5
Indication: Acute Myeloid Leukaemia
Possible Cytarabine side effects in
Reported by a individual with unspecified qualification from United States on 2012-06-27
Patient:
Reactions: Blood Bilirubin Increased, Vomiting, Nausea, Anaemia, Rash, Fatigue, Aspartate Aminotransferase Increased, Adverse Event, Neutropenia, Rash Maculo-Papular, Thrombocytopenia, Decreased Appetite
Adverse event resulted in: death
Drug(s) suspected as cause:
Revlimid
Administration route: Oral
Revlimid
Dosage: 10mg-25mg
Administration route: Oral
Revlimid
Dosage: 50 milligram
Administration route: Oral
Revlimid
Dosage: 10mg-25mg
Administration route: Oral
Cytarabine
Dosage: 1.5 milligram/sq. meter
Cytarabine
Dosage: 10 milligram
Possible Cytarabine side effects in male
Reported by a individual with unspecified qualification from Italy on 2012-06-18
Patient: male
Reactions: Epstein-Barr Virus Infection, Diarrhoea, Anaemia, Sepsis, Cytomegalovirus Infection, Neutropenia, Thrombocytopenia, Infection
Adverse event resulted in: death
Drug(s) suspected as cause:
Cyclophosphamide
Indication: Burkitt's Lymphoma
Methotrexate
Indication: Burkitt's Lymphoma
Vincristine Sulfate
Indication: Burkitt's Lymphoma
Cytarabine
Indication: Burkitt's Lymphoma
Cisplatin
Indication: Burkitt's Lymphoma
Methylprednisolone
Indication: Burkitt's Lymphoma
Etoposide
Indication: Burkitt's Lymphoma
Mabthera
Indication: Burkitt's Lymphoma
Doxorubicin Hydrochloride
Indication: Burkitt's Lymphoma
Possible Cytarabine side effects in male
Reported by a physician from Italy on 2012-06-14
Patient: male
Reactions: Epstein-Barr Virus Infection, Anaemia, Cytomegalovirus Infection, Neutropenia, Thrombocytopenia, Disease Progression, Infection
Drug(s) suspected as cause:
Carmustine
Indication: Burkitt's Lymphoma
Carboplatin
Indication: Burkitt's Lymphoma
Rituximab
Indication: Burkitt's Lymphoma
Etoposide
Indication: Burkitt's Lymphoma
Cytarabine
Indication: Burkitt's Lymphoma
Vincristine
Indication: Burkitt's Lymphoma
Melphalan Hydrochloride
Indication: Burkitt's Lymphoma
Radiotherapy
Indication: Burkitt's Lymphoma
Cyclophosphamide
Indication: Burkitt's Lymphoma
Cisplatin
Indication: Burkitt's Lymphoma
Doxorubicin HCL
Indication: Burkitt's Lymphoma
Methotrexate
Indication: Burkitt's Lymphoma
Ifosfamide
Indication: Burkitt's Lymphoma
Granulocyte Colony Stimulating Factor
Indication: Burkitt's Lymphoma
Methylprednisolone
Indication: Burkitt's Lymphoma
Unknown Medication
Dosage: antimicrobial prophylaxis
Indication: Burkitt's Lymphoma
Other drugs received by patient: Unknown Medication
Possible Cytarabine side effects in male
Reported by a physician from Italy on 2012-06-11
Patient: male
Reactions: Pruritus, Renal Failure, Anaemia, Hypocalcaemia, Erythema, Thrombocytopenia
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Mabthera
Indication: non-Hodgkin's Lymphoma
Start date: 2012-03-14
End date: 2012-04-26
Cisplatin
Indication: non-Hodgkin's Lymphoma
Start date: 2012-03-14
End date: 2012-04-26
Cytarabine
Indication: non-Hodgkin's Lymphoma
Start date: 2012-03-14
End date: 2012-04-26
Other drugs received by patient: Tenormin; Dexamethasone Sodium Phosphate; Lasix; Navoban; Ramipril; Trimeton; Levothyroxine Sodium; Aspirin
Possible Cytarabine side effects in 69 year old male
Reported by a physician from Italy on 2012-06-07
Patient: 69 year old male
Reactions: Pruritus, Renal Failure, Anaemia, Hypocalcaemia, Thrombocytopenia, Erythema
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Cisplatin
Dosage: 200 mg, cyclic
Indication: non-Hodgkin's Lymphoma
Start date: 2012-03-14
End date: 2012-04-26
Cytarabine
Dosage: 4000 mg, cyclic
Indication: non-Hodgkin's Lymphoma
Start date: 2012-03-14
End date: 2012-04-26
Mabthera
Dosage: 700 mg, cyclic
Indication: non-Hodgkin's Lymphoma
Start date: 2012-03-14
End date: 2012-04-26
Other drugs received by patient: Levothyroxine Sodium; Ramipril; Lasix; Tenormin; Trimeton; Navoban; Aspirin; Dexamethasone Sodium Phosphate
Possible Cytarabine side effects in male
Reported by a health professional (non-physician/pharmacist) from United States on 2012-06-05
Patient: male, weighing 102.6 kg (225.7 pounds)
Reactions: Cardio-Respiratory Arrest, Respiratory Failure, Anaemia, Troponin I Increased, Thrombocytopenia, Infection
Adverse event resulted in: death, life threatening event, hospitalization
Drug(s) suspected as cause:
Methotrexate
Dosage: 1600 mg, cyclic
End date: 2011-07-28
Adriamycin PFS
Dosage: 101 mg, cyclic
Indication: Mantle Cell Lymphoma
Start date: 2011-07-05
End date: 2011-07-05
Rituximab
Dosage: 750 mg, cyclic
Indication: Mantle Cell Lymphoma
Start date: 2011-07-01
End date: 2011-07-26
Methotrexate
Dosage: 400 mg, cyclic
Indication: Mantle Cell Lymphoma
End date: 2011-07-27
Cytarabine
Dosage: 6 g, cyclic
Indication: Mantle Cell Lymphoma
End date: 2011-07-30
Dexamethasone
Dosage: 40 mg, cyclic
Indication: Mantle Cell Lymphoma
Dexamethasone
Dosage: 20 unk, unk
Administration route: Oral
End date: 2011-07-15
Vincristine
Dosage: 2 mg, cyclic
Indication: Mantle Cell Lymphoma
Start date: 2011-07-05
End date: 2011-07-12
Velcade
Dosage: 2.6 mg, cyclic
Indication: Mantle Cell Lymphoma
Start date: 2011-07-01
End date: 2011-07-26
Cyclophosphamide
Dosage: 603 mg, cyclic
Indication: Mantle Cell Lymphoma
Start date: 2011-07-02
End date: 2011-07-04
Other drugs received by patient: Filgrastim; Ferrous Sulfate TAB; Heparin; Senokot; Triamcinolone Acetonide; Compazine; Ciprofloxacin; Fluconazole; Omeprazole; Mesna; Prevident; Valtrex; Vitamin C / 00008001 /; Methylprednisolone; Periogard; Ultram; Vitamin D
Possible Cytarabine side effects in 38 year old female
Reported by a physician from United States on 2012-06-01
Patient: 38 year old female
Reactions: Neutropenia, Thrombocytopenia
Drug(s) suspected as cause:
Cyclophosphamide
Indication: Acute Lymphocytic Leukaemia
Start date: 2012-04-13
Mesna
Indication: Acute Lymphocytic Leukaemia
Cytarabine
Indication: Acute Lymphocytic Leukaemia
Start date: 2012-04-13
Doxorubicin HCL
Indication: Acute Lymphocytic Leukaemia
Methotrexate
Indication: Acute Lymphocytic Leukaemia
Dexamethasone
Indication: Acute Lymphocytic Leukaemia
Vincristine
Indication: Acute Lymphocytic Leukaemia
Dasatinib
Administration route: Oral
Indication: Acute Lymphocytic Leukaemia
Start date: 2012-04-13
Possible Cytarabine side effects in 52 year old male
Reported by a health professional (non-physician/pharmacist) from United States on 2012-05-31
Patient: 52 year old male
Reactions: Haemoptysis, Acute Myeloid Leukaemia, Myelodysplastic Syndrome Transformation, Local Swelling, Hypokalaemia, Pneumonia Cytomegaloviral, Pulmonary Haemorrhage, Zygomycosis, Neutropenia, Thrombocytopenia
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Clofarabine
Idarubicin HCL
Idarubicin HCL
Dosage: 6 milligram/sq. meter
Indication: Myelodysplastic Syndrome
Cytarabine
Vidaza
Indication: Myelodysplastic Syndrome
Cytarabine
Dosage: 6 g/m2
Indication: Myelodysplastic Syndrome
Vidaza
Clofarabine
Dosage: 22.5 milligram/sq. meter
Indication: Myelodysplastic Syndrome
Other drugs received by patient: Fluconazole; Ciprofloxacin; Acyclovir; Metformin HCL; Insulin
Possible Cytarabine side effects in male
Reported by a physician from United States on 2012-05-24
Patient: male, weighing 103.3 kg (227.3 pounds)
Reactions: Rectal Haemorrhage, Anaemia, Blood Blister, Petechiae, Headache, Haemolysis, Dysgeusia, Ecchymosis, Thrombocytopenia, Papule
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Mercaptopurine
Dosage: 3900 mg
Cytarabine
Dosage: 2890 mg
Cyclophosphamide
Dosage: 4600 mg
Methotrexate
Dosage: 60 mg
PEG-L-Asparaginase (K-H)
Dosage: 5700 unit
Vincristine Sulfate
Dosage: 4 mg
Page 1 Next >>
|